APIC-A2M is now ALPHA2ACTIVE™! We’ve redesigned our patented, 510(k) approved Alpha-2-Macroglobulin (A2M) therapy to reflect the worldwide expansion to come and give you an edge as you reopen in today’s medical climate. ALPHA2ACTIVE™ may have a fresh new look, but the single-use kits include the same easy processing steps, high A2M concentration and protease binding benefits as before.
Innovation and Healthcare
ALPHA2ACTIVE™ is an exciting
advancement in orthopedic
science resulting from years of
osteoarthritis research. For the
majority of people with pain, their
arthritic joint or disc space houses more destructive enzymes than the body can handle.
Alpha-2-Macroglobulin, more commonly
referred to as A2M, is a master protease inhibitor that already exists in your blood and acts as a powerful inhibitor of cartilage breakdown.
It is our body’s own defense mechanism. This special molecule works by binding to the enzymes (proteases) that degrade the cartilage cells and tissue. However, it is too big and complex to enter the joint or disc space in large enough quantities. As a result, it is necessary to inject additional concentrated A2M into the affected area to restore balance and relieve pain.
MazMed
Get in touch!
Email: info@mazmedinc.com
Tel: 718 916 2224